Clinical Trial Update: Study Evaluating Efficacy and Safety of OSU6162 in the Treatment of Residual Symptoms After Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of OSU6162 for residual symptoms after stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Sequelae

Drugs mentioned

• OSU6162 (OSU6162)

Snippet

Sponsor: Arvid Carlsson Research AB | Conditions: Stroke Sequelae | Phase 2 | Status: COMPLETED